In silico approach to evaluate molecular interaction between mycotoxins and the estrogen receptors ligand binding domain: A case study on zearalenone and its metabolites

Toxicology Letters

Volumn 214, Issue 1, 2012, Pages 81-85

  Cozzini, Pietro ^a   Dellafiora, Luca ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Food safety; In silico screening; Molecular modeling; Toxins; Zearalenone

Indexed keywords

11 [4 [[5 [(4,4,5,5,5 PENTAFLUOROPENTYL)SULFONYL]PENTYL]OXY]PHENYL]ESTRADIOL; AFLATOXIN B1; ALPHA ZEARALENOL; ALPHA ZERALANOL; ANTIESTROGEN; ARGININE; BETA ZEARALENOL; BETA ZERALANOL; COUMESTROL; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GENISTEIN; HISTIDINE; ICI 165384; MYCOTOXIN; QUERCETIN; UNCLASSIFIED DRUG; ZEARALANONE; ZEARALENONE; ZEARALENONE 14 SULFATE;

COMPUTER AIDED DESIGN; COMPUTER SIMULATION; DRUG DESIGN; ESTROGEN ACTIVITY; FOOD SAFETY; LETTER; LIGAND BINDING; METABOLITE; MOLECULAR DOCKING; MOLECULAR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; RELIABILITY;

AMINO ACID SEQUENCE; ARTIFICIAL INTELLIGENCE; BINDING SITES; COMPUTER SIMULATION; ESTROGEN RECEPTOR ALPHA; ESTROGENS; MODELS, CHEMICAL; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN ISOFORMS; ZEARALENONE;

EID: 84865651203     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2012.07.023     Document Type: Letter

References (38)

1. Amadasi A., Mozzarelli A., Meda C., Maggi A., Cozzini P. Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach. Chemical Research in Toxicology 2009, 22(January (1)):52-63.
2. Amadasi A., Spyrakis F., Cozzini P., Abraham D.J., Kellogg G.E., Mozzarelli A. Mapping the energetics of water-protein and water-ligand interactions with the " natural" HINT forcefield: predictive tools for characterizing the roles of water in biomolecules. Journal of Molecular Biology 2006, 358:289-309.
3. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engström O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997, 389(October (6652)):753-758.
4. Cozzini P., Dottorini T. Is it possible docking and scoring new ligands with few experimental data? Preliminary results on estrogen receptor as a case study. European Journal of Medical Chemistry 2004, 39(July (7)):601-609.
5. Cozzini P., Fornabaio M., Marabotti A., Abraham D.J., Kellogg G.E., Mozzarelli A. Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 1: models without explicit constrained water. Journal of Medicinal Chemistry 2002, 45:2469-2483.
6. Cozzini P., Ingletto G., Singh R., Dall'Asta C. Mycotoxin detection plays " cops and robbers" : cyclodextrin chemosensors as specialized police?. International Journal of Molecular Sciences 2008, 9(December (12)):2474-2494.
7. EFSA Panel on Contaminants in the Food Chain (CONTAM) Scientific opinion on the risks for public health related to the presence of zearalenone in food. EFSA Journal 2011, 9(6):2197.
8. Fang H., Tong W., Perkins R., Soto A.M., Prechtl N.V., Sheehan D.M. Quantitative comparisons of in vitro assays for estrogenic activities. Environmental Health Perspectives 2000, 108(August (8)):723-729.
9. Fornabaio M., Cozzini P., Mozzarelli A., Abraham D.J., Kellogg G.E. Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 2: computational titration and pH effects in molecular models of neuraminidase-inhibitor complexes. Journal of Medicinal Chemistry 2003, 46:4487-4500.
10. Fornabaio M., Spyrakis F., Mozzarelli A., Cozzini P., Abraham D.J., Kellogg G.E. Simple, intuitive calculations of free energy of binding for protein-ligand complexes. 3: the free energy contribution of structural water molecules in HIV-1 protease complexes. Journal of Medicinal Chemistry 2004, 47:4507-4516.
11. Frizzell C., Ndossi D., Verhaegen S., Dahl E., Eriksen G., Sørlie M., Ropstad E., Muller M., Elliott C.T., Connolly L. Endocrine disrupting effects of zearalenone, alpha- and beta-zearalenol at the level of nuclear receptor binding and steroidogenesis. Toxicology Letters 2011, 206(October (2)):210-217.
12. Greene G.L., Shiau A.K., Nettles K.W. A structural explanation for ERalpha/ERbeta SERM discrimination. Proceeding of Ernst Schering Research Foundation Workshop 2004, (46):33-45.
13. Kang H.K., Choi Y.H., Kwon H., Lee S.B., Kim D.H., Sung C.K., Park Y.I., Dong M.S. Estrogenic/antiestrogenic activities of a Epimedium koreanum extract and its major components: in vitro and in vivo studies. Food and Chemical Toxicology 2012, 50(August (8)):2751-2759.
14. Kuiper G.G., Carlsson B., Grandien K., Enmark E., Häggblad J., Nilsson S., Gustafsson J.A. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997, 138(March (3)):863-870.
15. Kumar R., Thompson E.B. The structure of the nuclear hormone receptors. Steroids 1999, 64(May (5)):310-319.
16. Kumar R., Zakharov M.N., Khan S.H., Miki R., Jang H., Toraldo G., Singh R., Bhasin S., Jasuja R. The dynamic structure of the estrogen receptor. Journal of Amino Acids 2011, 2011:812540.
17. Li H., Ung C.Y., Yap C.W., Xue Y., Li Z.R., Chen Y.Z. Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. Journal of Molecular Graphics and Modelling 2006, 25(November (3)):313-323.
18. MacGregor J.I., Jordan V.C. Basic guide to the mechanisms of antiestrogen action. Pharmacological Review 1998, 50(June (2)):151-196.
19. Marabotti A., Spyrakis F., Facchiano A., Cozzini P., Alberti S., Kellogg G.E., Mozzarelli A. Energy-based prediction of amino acid-nucleotide base recognition. Journal of Computational Chemistry 2008, 29:1955-1969.
20. Massart F., Harrell J.C., Federico G., Saggese G. Human breast milk and xenoestrogen exposure: a possible impact on human health. Journal of Perinatology 2005, 25(April (4)):282-288.
21. Massart F., Saggese G. Oestrogenic mycotoxin exposures and precocious pubertal development. International Journal of Andrology 2010, 33(April (2)):369-376.
22. Minervini F., Giannoccaro A., Cavallini A., Visconti A. Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters. Toxicology Letters 2005, 159(December (3)):272-283.
23. Nishihara T., Nishikawa J., Kanayama T., Dakeyama F., Saito K., Imagawa M., Takatori S., Kitagawa Y., Hori S., Utsumic H. Estrogenic Activities of 517 Chemicals by Yeast Two-Hybrid Assay. Journal of Health Science 2000, 46(June (4)):282-298.
24. Ogawa Y., Kawamura Y., Wakui C., Mutsuga M., Nishimura T., Tanamoto K. Estrogenic activities of chemicals related to food contact plastics and rubbers tested by the yeast two-hybrid assay. Food Additives and Contaminants 2006, 23(April (4)):422-430.
25. Parker M.G. Transcriptional activation by oestrogen receptors. Biochemical Society Symposium 1998, 63:45-50.
26. Pike A.C., Brzozowski A.M., Hubbard R.E. A structural biologist's view of the oestrogen receptor. Journal of Steroid Biochemistry and Molecular Biology 2000, 74(November (5)):261-268.
27. Powell E., Wang Y., Shapiro D.J., Xu W. Differential requirements of Hsp90 and DNA for the formation of estrogen receptor homodimers and heterodimers. Journal of Biological Chemistry 2010, 285(May (21)):16125-16134.
28. Sabbah M., Kang K.I., Tora L., Redeuilh G. Oestrogen receptor facilitates the formation of preinitiation complex assembly: involvement of the general transcription factor TFIIB. Biochemical Journal 1998, 336(December (Pt 3)):639-646.
29. Salsi E., Bayden A.S., Spyrakis F., Amadasi A., Campanini B., Bettati S., Dodatko T., Cozzini P., Kellogg G.E., Cook P.F., Roderick S.L., Mozzarelli A. Design of O-acetylserine sulfhydrylase inhibitors by mimicking nature. Journal of Medicinal Chemistry 2010, 53(January (1)):345-356.
30. Savkur R.S., Burris T.P. The coactivator LXXLL nuclear receptor recognition motif. Journal of Peptide Research 2004, 63(March (3)):207-212.
31. Shanle E.K., Xu W. Endocrine disrupting chemicals targeting estrogen receptor signaling: identification and mechanisms of action. Chemical Research in Toxicology 2011, 24(January (1)):6-19.
32. Shier W.T., Shier A.C., Xie W., Mirocha C.J. Structure-activity relationships for human estrogenic activity in zearalenone mycotoxins. Toxicon 2001, 39(September (9)):1435-1438.
33. Spyrakis F., Cozzini P. How computational methods try to disclose the estrogen receptor secrecy-modeling the flexibility. Current Medicinal Chemistry 2009, 16(23):2987-3027.
34. Takemura H., Shim J.Y., Sayama K., Tsubura A., Zhu B.T., Shimoi K. Characterization of the estrogenic activities of zearalenone and zeranol in vivo and in vitro. Journal of Steroid Biochemistry and Molecular Biology 2007, 103(February (2)):170-177.
35. Vekiru E., Hametner C., Mitterbauer R., Rechthaler J., Adam G., Schatzmayr G., Krska R., Schuhmacher R. Cleavage of zearalenone by Trichosporon mycotoxinivorans to a novel nonestrogenic metabolite. Applied and Environment Microbiology 2010, 76(April (7)):2353-2359.
36. Vendl O., Berthiller F., Crews C., Krska R. Simultaneous determination of deoxynivalenol, zearalenone, and their major masked metabolites in cereal-based food by LC-MS-MS. Analytical and Bioanalytical Chemistry 2009, 395(November (5)):1347-1354.
37. Wärnmark A., Treuter E., Gustafsson J.A., Hubbard R.E., Brzozowski A.M., Pike A.C. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha. Journal of Biological Chemistry 2002, 277(June (24)):21862-21868.
38. Zinedine A., Soriano J.M., Moltó J.C., Mañes J. Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin. Food and Chemical Toxicology 2007, 45(January (1)):1-18.